dimaprit has been researched along with Idiopathic Parkinson Disease in 1 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the safety of long-term use of these ATP-competitive LRRK2 kinase inhibitors has been challenged by several studies." | 2.66 | Allosteric inhibition of LRRK2, where are we now. ( Cankara, FN; Kortholt, A; Soliman, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soliman, A | 1 |
| Cankara, FN | 1 |
| Kortholt, A | 1 |
1 review available for dimaprit and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Allosteric inhibition of LRRK2, where are we now.
Topics: Adenosine Triphosphate; Allosteric Site; Animals; Crystallography, X-Ray; Cytosol; Dimaprit; Dimeriz | 2020 |